推荐产品
描述
non-ionic
质量水平
分子量
average Mn ~735
折射率
n20/D 1.487 (lit.)
密度
1.104 g/mL at 25 °C (lit.)
HLB
14
SMILES字符串
CC(C)(C)CC(C)(C)c1ccc(OCCOCCOCCOCCOCCOCCOCCO)cc1
InChI
1S/C28H50O8/c1-27(2,3)24-28(4,5)25-6-8-26(9-7-25)36-23-22-35-21-20-34-19-18-33-17-16-32-15-14-31-13-12-30-11-10-29/h6-9,29H,10-24H2,1-5H3
InChI key
HNLXNOZHXNSSPN-UHFFFAOYSA-N
一般描述
IGEPAL® CA-720是一种非离子型聚氧乙烯表面活性剂。在溶剂乳液清洁剂中用作非极性溶剂的有效乳化剂。也用作淋洗液，通过电动强化原位淋洗除去低渗透性粘土中的多环芳烃(PAH)。
应用
IGEPAL® CA-720用途：
- 作为逆转录(RT)混合液组分，用于收获分选细胞的可变重链-轻链对(VH/VL)
- 用于重要的检测试剂盒
- 作为电动(EK)法中的表面活性剂去除有机污染物
- 作为Igepal和甲苯二元混合物组分，测定其密度 (ρ)和动力粘度(η)，研究表面活性剂和助表面活性剂混合物中的分子相互作用。
特点和优势
- 稳定性和持久性提高
- 良好的润湿性能
法律信息
IGEPAL is a registered trademark of Solvay
警示用语：
Danger
危险分类
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Irrit. 2
WGK
WGK 3
Surfactant and oxidant enhanced electrokinetic remediation of a PCBs polluted soil
Separation and Purification Technology null
Viscosity and Density of Binary Mixtures of Toluene + Igepal (CO-520, CO-630, CO-720, and CA-720) at T = 293.15-333.15 K and Atmospheric Pressure
Journal of Separation Science null
Zhijian Wu et al.
Journal of controlled release : official journal of the Controlled Release Society, 104(3), 497-505 (2005-05-25)
We investigate the controlled release of lidocaine hydrochloride from the doped silica-based xerogels. In the xerogel preparation, tetraethoxysilane (TEOS), methyltriethoxysilane (MTES), and propyltriethoxysilane (PTES) are used as precursors, and a nonionic surfactant Igepal CO 720 is used as a dopant.
Krishna R Reddy et al.
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, 39(5), 1189-1212 (2004-05-13)
Electrokinetically enhanced in-situ flushing using surfactants has the potential to remove polycyclic aromatic hydrocarbons (PAHs) from low permeability clay soils; however, previous research has shown that the applied electric potential produces complex physical, chemical, and electrochemical changes within clay soils
Joost Snijder et al.
Immunity, 48(4), 799-811 (2018-04-19)
Epstein-Barr virus (EBV) is a causative agent of infectious mononucleosis and is associated with 200,000 new cases of cancer and 140,000 deaths annually. Subunit vaccines against this pathogen have focused on the gp350 glycoprotein and remain unsuccessful. We isolated human
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门